...

Late in 1987, what was now called the FDA Center for Biologics Evaluation and Research licensed a more potent inactivated poliomyelitis vaccine. Improvements in cell culture and purification facilitated this new, more effective vaccine requiring three vaccinations doses instead of four. This vaccine was preferred for unimmunized adults and for children with suppressed immune systems.

...